pamidronate has been researched along with Follicular Thyroid Carcinoma in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Skeletal metastases from thyroid cancer are poorly responsive to medical or radioiodine treatment." | 2.70 | Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. ( Abbruzzese, A; Caraglia, M; Ciccarelli, A; Fonderico, F; Lupoli, G; Martignetti, A; Nuzzo, V; Vitale, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vitale, G | 1 |
| Fonderico, F | 1 |
| Martignetti, A | 1 |
| Caraglia, M | 1 |
| Ciccarelli, A | 1 |
| Nuzzo, V | 1 |
| Abbruzzese, A | 1 |
| Lupoli, G | 1 |
1 trial available for pamidronate and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Analgesics; Anti-Inflammatory Agents; Bone Neoplasms; Bone | 2001 |